88

News

Novo Nordisk’s big hope green-lighted in the US

Christian Wenande
October 19th, 2017


This article is more than 7 years old.

New diabetes product could be its golden egg

Good news in the US (photo: Novo Nordisk)

It’s been tough goings for Novo Nordisk in the US recently. But finally the Danish pharmaceutical giant has something to smile about across the Atlantic.

Yesterday, the US Food and Drug Administration (FDA) approved Semaglutide, the Novo Nordisk product designed to improve glycaemic control in adults with type 2 diabetes.

“This is going to mean the world for Novo Nordisk. This product has massive potential within the treatment of diabetes,” Søren Løntoft Hansen, an analyst with Sydbank, told Børsen newspaper.

“This has the potential to make up the spine of Novo Nordisk’s turnover and profit looking ten years ahead.”

READ MORE: Lego and Novo Nordisk among most desirable companies to work for in Denmark

Billions on the line
Some 16 out of 17 members of the FDA expert panel voted in favour of approving Semaglutide, while the final member abstained. Final approval is expected to come on December 5.

Information collected by Bloomberg News indicates that Semaglutid sales are expected to rake in more than 2 billion kroner in 2018 and increase to 11.6 billion kroner in 2020.

The good news comes just days after Novo Nordisk was ranked one of the most desirable companies to work for by university students in Denmark.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”